| 1 |
Li J, Yang C, Zheng Y. Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses. Front Genet 2022;13:1088230. [PMID: 36685946 DOI: 10.3389/fgene.2022.1088230] [Reference Citation Analysis]
|
| 2 |
Dai X, Zeng M, Huang Z, Zhang J, Wei Z, Wang Z. A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma. Disease Markers 2022;2022:1-38. [DOI: 10.1155/2022/2823042] [Reference Citation Analysis]
|
| 3 |
Quan Y, Zhang X, Wang M, Ping H. Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation. Front Oncol 2022;12:981226. [DOI: 10.3389/fonc.2022.981226] [Reference Citation Analysis]
|
| 4 |
Xie H, Shi M, Liu Y, Cheng C, Song L, Ding Z, Jin H, Cui X, Wang Y, Yao D, Wang P, Yao M, Zhang H. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma. Front Immunol 2022;13:914977. [DOI: 10.3389/fimmu.2022.914977] [Reference Citation Analysis]
|
| 5 |
Li J, Xiang R, Song W, Wu J, Kong C, Fu T. A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer Patients. Front Genet 2022;13:899419. [DOI: 10.3389/fgene.2022.899419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Liang X, Yu G, Zha L, Guo X, Cheng A, Qin C, Zhang H, Wang Z. Identification and Comprehensive Prognostic Analysis of a Novel Chemokine-Related lncRNA Signature and Immune Landscape in Gastric Cancer. Front Cell Dev Biol 2021;9:797341. [PMID: 35096827 DOI: 10.3389/fcell.2021.797341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Quan Y, Zhang X, Ping H. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-021-02438-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
